292
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Physicochemical Characterization of Interaction of Ibuprofen by Solid-State Milling with Aluminum Hydroxide

, , , , , & show all
Pages 726-734 | Published online: 25 Sep 2008

REFERENCES

  • Barzegar-Jalali M., Nayebi A. M., Valizadeh H., Hanaee J., Barzegar-Jalali A., Adibkia K., Anoush M., Sistanizad M. Evaluation of in vitro–in vivo correlation and anticonvulsive effect of carbamazepine after cogrinding with microcrystalline cellulose. J. Pharm. Pharm. Sci. 2006; 9: 307–316
  • Buckton G., Choularton A., Beezer A. E., Chatham S. M. The effect of the comminution technique on the surface energy of a powder. Int. J. Pharm. 1988; 47: 121–128
  • Cirri M., Mura P., Rabasco A. M., Gines J. M., Moyano J. R., Gonzalez-Rodriguez M. L. Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev. Ind. Pharm. 2004; 30: 65–74
  • Crowley K. J., Zografi G. Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase physical stability. J. Pharm. Sci. 2002; 91: 492–507
  • Gupta M. K., Goldman D., Bogner R. H., Tseng Y.-C. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm. Dev. Tech. 2001; 6: 563–572
  • Gupta M. K., Vanwert A., Bogner R. H. Formation of physically stable amorphous drugs by milling with Neusilin. J. Pharm. Sci. 2003; 92: 536–551
  • Kararli T. T., Needham T. E., Suel C. J., Finnegan P. M. Solid state interaction of magnesium oxide and ibuprofen to form a salt. Pharm. Res. 1989; 6: 804–808
  • Kinoshita M., Baba K., Nagayasu A., Yamabe K., Shimooka T. Improvement of solubility and oral bioavailability of a poorly water soluble drug, TAS-301, by its melt adsorption on a porous calcium silicate. J. Pharm. Sci. 2002; 91: 362–370
  • Kitamura S., Miyamac A., Koda S., Morimoto Y. Effect of grinding on the solid state stability of cefixime trihydrate. Int. J. Pharm. 1989; 56: 125–134
  • Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000; 50: 47–60
  • Lober S., Ziege S., Ran M., Schreiber G., Mignot A., Koeppe P., Lode H. Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminium and magnesium. Antimicrob. Agents Chemother. 1999; 43: 1067–1071
  • Mallick S. The solid state amorphization of poorly water soluble drugs. Indian J. Pharm. Sci. 2004; 66: 729–734
  • Mallick S., Pattnaik S., Swain K., De P. K. Current perspectives of solubilization: Potential for improved bioavailability. Drug Dev. Ind. Pharm. 2007; 33: 865–873
  • Mallick S., Pattnaik S., Swain K., De P. K., Mondal A., Ghoshal G., Saha A. Interaction characteristics and thermodynamic behaviour of gatifloxacin by aluminium hydroxide. Drug Dev. Ind. Pharm. 2007; 33: 535–541
  • Mallick S., Pattnaik S., Swain K., De P. K., Saha A., Ghoshal G., Mondal A. Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin. Eur. J. Pharm. Biopharm. 2008; 68: 346–351, doi: 10.1016/j.ejpb.2007.06.003
  • Mallick S., Sahoo A., Mitra S. S. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions. Boll. Chim. Farmac. 2003; 142: 180–166
  • Moneghini M., Kikic I., Voinovich D., Perissutti B., Filipovic-Grcic. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: Preparation, characterization, and in vitro dissolution. Int. J. Pharm. 2001; 222: 129–138
  • Mora P. C, Cirri M., Guenther S., Allolio B., Carli F., Mura P. Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with alpha-cyclodextrin and glycine. J. Pharm. Sci. 2003; 92: 2177–2184
  • Mukne A. P., Nagarsenker M. S. Triamterene-beta-cyclodextrin systems: Preparation, characterization and in vivo evaluation. AAPS PharmSciTech 2004; 5: E19
  • Mura P., Bettinetti G. P., Cirri M., Maestrelli F., Sorrenti M., Catenacci L. Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-betacyclodextrin ternary system. Eur. J. Pharm. Biopharm. 2005a; 59: 99–106
  • Mura P., Furlanetto S., Cirri M., Maestrelli F., Corti G., Pinzauti S. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. J. Pharm. Biomed. Anal. 2005b; 37: 987–994
  • Nagarsenker M. S., Joshi M. S. Celecoxib–cyclodextrin systems: Characterization and evaluation of in vitro and in vivo advantage. Drug Dev. Ind. Pharm. 2005; 31: 169–178
  • Norimatsu M., Ogikubo Y., Aoki A., Takahashi T., Watanabe G., Taya K., Sasamoto S., Tsuchiya M., Tamura Y. Effects of aluminium adjuvant on systemic reactions of lipopolysaccharides in swine. Vaccine 1995; 13: 1325–1329
  • Otsuka M., Matsumoto T., Kareniwa N. Effect of environmental temperature on polymorphic solid state transformation of indomethacin during grinding. Chem. Pharm. Bull. 1986; 34: 1784–1793
  • Otsuka M., Ofusa T., Matsuda Y. Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding. Colloids Surf. 1999; 13: 263–273
  • Pignatello R., Spadaro D., Vandelli M. A., Forri F., Puglisi G. Characterization of the mechanism of interaction in ibuprofen–Eudragit RL 100® coevaporation. Drug Dev. Ind. Pharm. 2004; 30: 277–288
  • Rinaki E., Valsami G., Macheras P. Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio. Pharm. Res. 2003; 20: 1917–1925
  • Rinella J. V., White J. L., Hem S. L. Effect of pH on the elution of model antigens from aluminium containing adjuvants. J. Colloid Interf. Sci. 1998; 205: 161–165
  • Sarkari M., Brown J., Chen X., Swinnea S., Williams R. O., III, Johnston K. P. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 2002; 243: 17–31
  • Sharma S., Sher P., Badve S., Pawar A. P. Adsorption of Meloxicam on porous calcium silicate: Characterization and tablet formulation. AAPS Pharm SciTech 2005; 6(4), Article 76.
  • Shi Y., Hogenesch H., Regnier F. E., Hem S. L. Detoxification of endotoxin by aluminium hydroxide adjuvant. Vaccine 2001; 19: 1747–1752
  • Shirodkar S., Hutchinson R. L., Perry D. L., White J. L., Hem S. L. Aluminium compounds used as adjuvants in vaccines. Pharm. Res. 1990; 7: 1282–1288
  • Smirnova I., Suttiruengwong S., Seiier M., Arlt W. Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophyllic silica aerogel. Pharm. Dev. Technol. 2004; 9: 443–452
  • Sourek J., Kevin J., Trnka T., Zelenkova L. New trends in the use of Al(OH)3-conjugated endotoxins and their subunits from the vaccination purposes. Vaccine 1991; 9: 106–110
  • Teng R., Dogolo L. C., Willavize S. A., Friedman H. L., Vincent J. Effect of Maalox and omeprazole on bioavailability of trovafloxacin. J. Antimicrob. Chemother. 1997; 39: 93–97
  • Timmers K., Sternglanz. Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids. Bioinorg. Chem. 1978; 9: 145–155
  • Tong P., Taylor L. S., Zografi G. Influence of alkali metal counterions on the glass transition temperature of amorphous indomethacin salts. Pharm. Res. 2002; 19: 649–654
  • Watanabe T., Ohno I., Wakiyama N., Kusai A., Senna M. Stabilization of amorphous indomethacin by cogrinding in a ternary mixture. Int. J. Pharm. 2002; 241: 103–111
  • Zerrouk N., Mennini N., Maestrelli F., Chemtob C., Mura P. Comparison of the effect of chitosan and polyvinyl pyrrolidone on dissolution properties and analgesic effect of naproxen. Eur. J. Pharm. Biopharm. 2004; 57: 93–99

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.